Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CALM3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NSMAF - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CDK17 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
TLE1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KDELR3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TNPO2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
WWOX - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LCN1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MIR943 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EFNB3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KIAA1644 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PDK3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
C14orf1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DNMBP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HSF2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CLEC1A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PLK4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MAP2K4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on